Competitive Grants Program
Pfizer supports the global healthcare community’s independent initiatives (e.g., research, quality improvement or education) to improve patient outcomes in areas of unmet medical need that are aligned with Pfizer’s medical and/or scientific strategies.
Pfizer’s competitive grant program involves a publicly posted Request for Proposal (RFP) that provides detail regarding a specific area of interest and sets timelines for review and approval. Organizations are invited to submit an application addressing the specific gaps in research, practice or care as outlined in the specific RFP. The grant requester (and ultimately the grantee) is responsible for the design, implementation, sponsorship, and conduct of the independent initiative supported by the grant, including compliance with any regulatory requirements.
Sign up to receive all grant announcements, including Request for Proposal (RFP) postings.
Sign Up for Alerts DetailsTitle Grant Type Focus Area Country Application Due Date Pharmacokinetics-Pharmacodynamics (PK-PD) Profile, Effectiveness and Safety of ATM-AVI in Special PopulationsRelease Date:Research Inflammation & Immunology China Impact of Rapid Diagnostic Tests (RDTs) on Treatment Pattern and Outcomes in Patients with Carbapenem-Resistant (CR) PathogensRelease Date:Research Inflammation & Immunology China Initiatives to Improve the Clinical Environment for Dermatologic Immunology, Inflammation, and Allergy CareRelease Date:Partner: The Japanese Society for Cutaneous Immunology and AllergyQuality Improvement Inflammation & Immunology Japan Real World, Long-term Efficacy Study of Ritlecitinib in Adult and Adolescent Patients with Severe Alopecia Areata in ChinaRelease Date:Research Inflammation & Immunology China Epidemiology and surveillance of Gram-negative infections caused by carbapenemase-producing organisms (CPOs) in the UKRelease Date:Research Internal Medicine United Kingdom Advancing Care for Patients with Advanced ALK+ Non-Small Cell Lung Cancer (NSCLC)Education Oncology All Quality Improvement Solutions for the Diagnosis and Management of Migraine and Headache DisordersQuality Improvement Internal Medicine Canada, USA Shared Decision Making in Hemophilia Patient CareRelease Date:Quality Improvement Rare Disease China Real-World Atopic Dermatitis: Italian Insights GrantRelease Date:Research Inflammation & Immunology Italy Title Grant Type Focus Area Country Application Due Date Innovative digital educational channels in Oncology for health care professionals or patients to increase local awarenessRelease Date:Education Oncology Spain Individualized Menopause CareRelease Date:Education Internal Medicine USA Approaches to Improve Delivery of Quality of Care for Patients with Inflammatory, and Immune Skin DiseasesRelease Date:Quality Improvement Inflammation & Immunology Japan Promoting Appropriate Diagnosis and Treatment of Migraine CareRelease Date:Education Internal Medicine Japan Burden of RSV Disease - Analyzing Local Surveillance Data for Older Adults (EM Geographic Scope)Release Date:Research Inflammation & Immunology All Improving Education Disparities of Non-Specialized Health Care Providers to Deliver Appropriate Medical Care for IBD PatientsRelease Date:Education Inflammation & Immunology Argentina, Brazil, India, Russia, Saudi Arabia, Singapore, Turkey, United Arab Emirates Increasing Understanding of the Evolving Hemophilia Treatment LandscapeRelease Date:Education Rare Disease USA Non-Muscle Invasive Bladder Cancer Emerging Markets Needs AssessmentRelease Date:Education Oncology Argentina, Brazil, Colombia, Hong Kong, India, Mexico, Saudi Arabia, Taiwan, Turkey, United Arab Emirates Addressing Educational Barriers to Equitable Care for Patients with Immune Inflammatory DiseasesRelease Date:Education Inflammation & Immunology All Juvenile Idiopathic Arthritis (JIA) Patient EducationRelease Date:Education Inflammation & Immunology USA Updates on RSV in Older Adults for PharmacistsRelease Date:Education Vaccines USA PARP-inhibitor Combination Treatments in Prostate Cancer, a Global PerspectiveRelease Date:Education Oncology All